Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000490

Drug Information
NameDiphenhydramine
SynonymsSpectrum3_000400; KBio2_004028; CHEBI:127629; NCGC00015335-01; 2-(Benzhydryloxy)-N,N-dimethylethylamine, hydrochloride; NCI60_002916; Antitussive; SMR001307259; Benylan; Nytol Quickcaps; Mephadryl; Dormarex 2; D00300; Allergeval; Benzhydril; Dryistan; Diphenylhydramin; EINECS 200-396-7; N-(Benzhydryloksy-etylo)dwumetyloamina [Polish]; Prestwick0_000065; CAS-147-24-0; Benzhydramine; Baramine; Diphenhist; Diabenyl; BENADRYL HCl; PM 255; Diphenhydraminum; Histaxin; 2-[(diphenylmethyl)oxy]-N,N-dimethylethanamine; 2-(Benzhydryloxy)-N,N-dimethylethylamine; Antistominum; KBioGR_001099; Benadrin; diphenhydramine; STOCK2S-94461; I14-6749; O-Benzhydryldimethylaminoethanol; Betramin; Banophen Caplets; Genahist; STK103720; AKOS003658554; AC-13704; KBio3_001439; Spectrum5_000915; NCGC00015335-10; Bena; HSDB 3066; HMS2089E06; Beldin; Diphenhydraminum [INN-Latin]; Benapon; Dimedryl; Nervine Nighttime Sleep-Aid; Belix; Oprea1_254625; BSPBio_002219; Desentol; Diphenhydramine [INN:BAN:JAN]; Spectrum4_000520; IDI1_000368; Allermax Caplets; 147-24-0; Allergina; Debendrin; Syntedril; Difenhydramin; Dermodrin; BRD-K47278471-003-05-7; Diphenhydramine HCl; CHEMBL657; Allerdryl; Nausen; DIPHENHYDRAMINE, ANTISTOMINUM, BENZHYDRAMINE; NCGC00015335-02; 88637-37-0 (citrate (1:1)); Dihidral; Bagodryl; Ben-allergin; AB00053460; Medidryl; Alledryl; S51; NCI60_022782; Restamin (TN); 2-(diphenylmethoxy)-N,N-dimethylethanamine; NSC665800; beta-Dimethylaminoethylbenzhydrylether; Dabylen; Allergival; Benzantine; 2-(Diphenylmethoxy)-N,N-dimethylethylamine; Ibiodral; SPBio_000961; Compoz; DB01075; Dibenil; BIDD:GT0152; Diphenhydramine (JP15/INN); Difedryl; 2-Diphenylmethoxy-N,N-dimethylethylamine; Spectrum_000980; L000227; Difenidramina; Diphenhydramine Base; Benhydramin; Dimedrol; Benadryl (hydrochloride); N,N-Dimethyl-2-(diphenylmethoxy)-ethylamine hydrochloride; nchembio747-comp18; Diphen Cough; Probedryl; NCGC00024414-03; Benzhydryl; KBioSS_001460; Difenhidramina [INN-Spanish]; Benachlor; TL8003758; CCRIS 1959; Siladryl; Prestwick1_000065; Ethylamine, 2-(diphenylmethoxy)-N,N-dimethyl-; AC1L1F65; Dimedrol base; Amidryl; Difenhidramina; Benadryl; Restamin; 2-benzhydryloxyethyl-N,N-dimethylammonium; Hyrexin; BRN 1914136; alpha-(2-Dimethylaminoethoxy)diphenylmethane; BSPBio_000249; KBio2_001460; MLS002222276; Ethanamine, 2-(diphenylmethoxy)-N,N-dimethyl-; Diphantine; NCGC00024414-04; CPD-10890; KBio1_000368; 2PM; SPBio_002170; Prestwick3_000065; Antomin; Nytol Quickgels; Benadryl Allergy; Dylamon; NCGC00015335-03; FAR 90X2; beta-dimethylaminoethyl benzhydryl ether; DivK1c_000368; Twilite Caplets; Lopac0_000377; Lopac-D-3630; Rigidil; beta-Dimethylaminoethanol diphenylmethyl ether; MolPort-001-783-508; Benodine; Sleep-Eze D; Dibendrin; Drylistan; Aller-Med; Dimehydrinate; N-[2-(BENZHYDRYLOXY)ETHYL]-N,N-DIMETHYLAMINE; Automin; Unisom Sleepgels Maximum Strength; Allergan B; Dibondrin; Etanautine; LS-68208; Diphenhist Captabs; CID3100; CHEBI:4636; Prestwick2_000065; Ethylamine, N,N-dimethyl-2-(diphenylmethoxy)-; Syntodril; N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine; Benzhydraminum; Spectrum2_000961; beta-Dimethylamino-aethyl-benzhydryl-aether; Hydramine; Benylin; Diabylen; 58-73-1; N-(Benzhydryloksy-etylo)dwumetyloamina; 2-diphenylmethoxy-N,N-demthylethanamine; DB06975; Benodin; 2-benzhydryloxy-N,N-dimethylethanamine; UNII-8GTS82S83M; Diphenylhydramine; Dermistina; Sleep-Eze D Extra Strength; 147-24-0 (HYDROCHLORIDE); Hyadrine; Aleryl; beta-Dimethylamino-aethyl-benzhydryl-aether [German]; Difenidramina [Italian]; Benzhydroamina; NINDS_000368; Diphen; Allergical; BPBio1_000275; Novamina; Silphen; Banophen; KBio2_006596
Trade NameBenadryl; Dimedrol; Nytol
CompanyJohnson & Johnson
IndicationVertigo/Meniere's diseaseApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-1
6/h3-12,17H,13-14H2,1-2H3
InChIKeyZZVUWRFHKOJYTH-UHFFFAOYSA-N
Canonical SMILESCN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2    
Therapeutic ClassAnti-Allergic Agents
CAS NumberCAS 58-73-1
FormulaC17H21NO
PubChem Compound IDCID 3100.
PubChem Substance IDSID 148880.
SuperDrug ATC IDD04AA32; R06AA02
SuperDrug CAS ID000058731;
TargetHistamine H1 receptorAntagonist[2][3]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 040140 To Reference
Ref 2Intact cell binding for in vitro prediction of sedative and non-sedative histamine H1-receptor antagonists based on receptor internalization. J Pharmacol Sci. 2008 May;107(1):66-79. Epub 2008 Apr 29. To Reference
Ref 3Histamine as an autocrine regulator of leukemic cell proliferation. Leuk Lymphoma. 2000 Jan;36(3-4):367-73. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543